Preview

PULMONOLOGIYA

Advanced search

Chronic obstructive pulmonary disease: significance of risk factors for frequent exacerbations requiring hospitalization

https://doi.org/10.18093/0869-0189-2021-31-4-446-455

Abstract

Aim. Identification of risk factors for readmissions associated with an exacerbation of chronic obstructive pulmonary disease (COPD) followed by evaluation of quality of the medical care in the outpatient and hospital settings.

Methods. A retrospective analysis of the medical records of patients with an exacerbation of chronic obstructive pulmonary disease admitted to the multidisciplinary hospitals in Kazan from January 1, 2015 to December 31, 2018, was.

Results. The identified risk factors for readmission were male gender (relative risk (RR) 3.49; 95% confidence interval (CI) 1.45 – 8.43; p < 0.05), age over 70 years (RR 1.21; 95% CI 0.74 – 1.86; p < 0.05), smoking experience more than 40 years (RR 1.6; 95% CI 0.87 – 3.0; p < 0.05), duration of COPD at least 10 years (RR 3.48; 95% CI 2.27 – 5.34; p < 0.05), the presence of three or more concomitant diseases (RR 2.0; 95% CI 1.23 – 3.4; p < 0.05). The most significant reasons for readmissions were nonadherence in the outpatient settings, as well as defects in the therapy that was provided in the hospital and prescribed upon discharge.

Conclusion. The identified risk factors are non-modifiable in most cases, so optimizing treatment and monitoring patient adherence are of paramount importance. Also, more attention should be paid to nonpharmacological treatment in the form of maintaining physical activity, early smoking cessation and psychological rehabilitation. The revealed defects of the quality of medical care for patients with severe exacerbations requiring repeated hospitalizations indicate the need to intensify the implementation of the federal clinical guidelines on chronic obstructive pulmonary disease in the real clinical practice.

About the Authors

Aygul R. Zinnatullina
Kazan State Medical University, Healthcare Ministry of Russia: ul. Butlerova 49, Kazan, 420012, Tatarstan Republic
Russian Federation

Assistant of Department internal medicine


Competing Interests:

no



Rustem F. Khamitov
Kazan State Medical University, Healthcare Ministry of Russia: ul. Butlerova 49, Kazan, 420012, Tatarstan Republic
Russian Federation

Doctor of Medicine, professor, head of Department internal medicine

 


Competing Interests:

lectures for Materia Medica, Niarmedic, Sandoz, Astra Zeneсa, Beringer, Novartis, Petrovax



References

1. Lorenz J.,Bals R., Dreher M. et al. [Exacerbation of COPD]. Pneumologie. 2017: 71 (5): 269–289. DOI: 10.1055/s-0043-106559 (in German).

2. Hogea S.P., Tudorache E., Fildan A.P. et al. Risk factors of chronic obstructive pulmonary disease exacerbations. Clin. Respir. J. 2020; 14 (3): 183–197. DOI: 10.1111/crj.13129.

3. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2021 Report. Available at: https://goldcopd.org/2021-gold-reports/ [Accessed: January 14, 2021].

4. Russian Respiratory Society. [Chronic Obstructive Pulmonary Disease: Federal Clinical Guidelines.]. 2018. Available at: [Accessed: January 5, 2021] (in Russian).

5. Chazova I.E., Nevzorova V.A., Ambatiello L.G. et al. [Clinical practice guidelines on the diagnosis and treatment of patients with arterial hypertension and chronic obstructive pulmonary disease]. Sistemnye gipertenzii. 2020; 17 (3): 7–34. DOI: 10.26442/2075082X.2020.3.200294 (in Russian).

6. Pilcher J., Weatherall M., Perrin K., Beasley R. et al. Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. Expert Rev. Respir. Med. 2015; 9 (3): 287–293. DOI: 10.1586/17476348.2015.1016503.

7. Gunen H., Hacievliyagil S.S., Yetkin O. et al. The role of nebulized budesonide in the treatment of exacerbations of COPD. Eur. Respir. J. 2007; 29 (4): 660–667. DOI: 10.1183/09031936.00073506.

8. Toledo-Pons N., Cosio B.G. Is there room for theophylline in COPD? Arch. Bronconeumol. 2017; 53 (10): 539–540. DOI: 10.1016/j.arbr.2017.05.019 (in English, Spanish).

9. Dvoretskiy L.I. [Community-acquired pneumonia in patients with chronic obstructive pulmonary disease]. Prakticheskaya pul’monologiya. 2015; (2): 17–21. Available at: http://www.atmosphere-ph.ru/modules/Magazines/articles/pulmo/PP_2_2015_17.pdf (in Russia).

10. Martinez-Garcia M.A., Miravitlles М. Bronchiectasis in COPD patients: more than a comorbidity? Int. J. Chron. Obstruct. Pulmon. Dis. 2017; 12: 1401–1411. DOI: 10.2147/COPD.S132961.

11. Storgaard L.H., Hockey H.U., Laursen B.S., Weinreich U.M. Longterm effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure. Int. J. Chron. Obstruct. Pulmon. Dis. 2018; 13: 1195–1205. DOI: 10.2147/COPD.S159666.


Review

For citations:


Zinnatullina A.R., Khamitov R.F. Chronic obstructive pulmonary disease: significance of risk factors for frequent exacerbations requiring hospitalization. PULMONOLOGIYA. 2021;31(4):446-455. (In Russ.) https://doi.org/10.18093/0869-0189-2021-31-4-446-455

Views: 740


ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)